Yuetiva Deming, Ph.D.
Affiliations: | 2011-2018 | Department of Psychiatry | Washington University School of Medicine, St. Louis, MO, United States |
| 2018- | Department of Medicine | University of Wisconsin, Madison, Madison, WI |
Area:
Genetics, NeuroscienceGoogle:
"Yuetiva Deming"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Krista M. Rodgers | research assistant | 2009-2011 | CU Boulder | |
| (I was an undergraduate research assistant) | ||||
| Carlos Cruchaga | grad student | 2011-2017 | Washington University School of Medicine | |
| Barbara B. Bendlin | post-doc | 2018- | UW Madison | |
| Corinne D. Engelman | post-doc | 2018- | UW Madison (Epi Tree) | |
| Carlos Cruchaga | post-doc | 2017-2018 | Washington University School of Medicine in St. Louis | |
Collaborators
Sign in to add collaborator| Logan C. Dumitrescu | collaborator | 2017- | Vanderbilt (Computational Biology Tree) |
| Michael Ewers | collaborator | 2017- | Ludwig Maximilian University Munich |
| Christian Haass | collaborator | 2017- | Ludwig Maximilian University Munich |
| Timothy J. Hohman | collaborator | 2017- | Vanderbilt |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dumitrescu L, Barnes LL, Thambisetty M, et al. (2019) Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589 |
| Ewers M, Franzmeier N, Suárez-Calvet M, et al. (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Science Translational Medicine. 11 |
| Li Z, Farias FHG, Dube U, et al. (2019) The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathologica |
| Deming Y, Filipello F, Cignarella F, et al. (2019) The gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Science Translational Medicine. 11 |
| Suárez-Calvet M, Morenas-Rodríguez E, Kleinberger G, et al. (2019) Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Molecular Neurodegeneration. 14: 1 |
| Suárez-Calvet M, Capell A, Araque Caballero MÁ, et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine |
| Maxwell TJ, Corcoran C, Del-Aguila JL, et al. (2018) Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels. Alzheimer's Research & Therapy. 10: 86 |
| Deming Y, Dumitrescu L, Barnes LL, et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathologica |
| Deming Y, Li Z, Benitez BA, et al. (2018) Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opinion On Therapeutic Targets |
| Fernández MV, Budde J, Del-Aguila JL, et al. (2018) Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease. Frontiers in Neuroscience. 12: 209 |